- Home
- NERV vs ZCMD Comparison
NERV vs ZCMD Comparison
Compare NERV & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- ZCMD
- Stock Information
- Founded
- NERV 2007
- ZCMD 2012
- Country
- NERV United States
- ZCMD China
- Employees
- NERV N/A
- ZCMD N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- ZCMD Other Consumer Services
- Sector
- NERV Health Care
- ZCMD Real Estate
- Exchange
- NERV Nasdaq
- ZCMD Nasdaq
- Market Cap
- NERV 14.6M
- ZCMD 17.3M
- IPO Year
- NERV 2014
- ZCMD 2020
- Fundamental
- Price
- NERV $3.73
- ZCMD $0.67
- Analyst Decision
- NERV Hold
- ZCMD
- Analyst Count
- NERV 1
- ZCMD 0
- Target Price
- NERV $4.00
- ZCMD N/A
- AVG Volume (30 Days)
- NERV 8.7M
- ZCMD 184.7K
- Earning Date
- NERV 11-05-2025
- ZCMD 01-01-0001
- Dividend Yield
- NERV N/A
- ZCMD N/A
- EPS Growth
- NERV N/A
- ZCMD N/A
- EPS
- NERV N/A
- ZCMD N/A
- Revenue
- NERV N/A
- ZCMD $13,117,523.00
- Revenue This Year
- NERV N/A
- ZCMD N/A
- Revenue Next Year
- NERV N/A
- ZCMD N/A
- P/E Ratio
- NERV N/A
- ZCMD N/A
- Revenue Growth
- NERV N/A
- ZCMD N/A
- 52 Week Low
- NERV $1.15
- ZCMD $0.60
- 52 Week High
- NERV $12.46
- ZCMD $2.50
- Technical
- Relative Strength Index (RSI)
- NERV 51.45
- ZCMD 40.46
- Support Level
- NERV $3.50
- ZCMD $0.60
- Resistance Level
- NERV $4.00
- ZCMD $0.75
- Average True Range (ATR)
- NERV 0.95
- ZCMD 0.08
- MACD
- NERV -0.13
- ZCMD 0.01
- Stochastic Oscillator
- NERV 11.92
- ZCMD 54.98
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.